Home/Filings/4/0001264908-10-000003
4//SEC Filing

GRANGE DAVID L 4

Accession 0001264908-10-000003

CIK 0001003124other

Filed

Nov 3, 8:00 PM ET

Accepted

Nov 4, 4:15 PM ET

Size

18.6 KB

Accession

0001264908-10-000003

Insider Transaction Report

Form 4
Period: 2010-11-02
GRANGE DAVID L
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2010-11-02$21.98/sh+373$8,19961,418 total
  • Sale

    Common Stock

    2010-11-02$26.00/sh373$9,69861,045 total
  • Exercise/Conversion

    Stock Options (to buy)

    2010-11-0351,380155,259 total
    Exercise: $21.98From: 2010-07-01Exp: 2019-07-01Common Stock (51,380 underlying)
  • Sale

    Common Stock

    2010-11-03$25.71/sh51,380$1,320,98061,045 total
  • Exercise/Conversion

    Stock Options (to buy)

    2010-11-02373206,639 total
    Exercise: $21.98From: 2010-07-01Exp: 2019-07-01Common Stock (373 underlying)
  • Exercise/Conversion

    Common Stock

    2010-11-03$21.98/sh+51,380$1,129,332112,425 total
Holdings
  • Stock Options (to buy)

    Exercise: $26.64From: 2011-06-17Exp: 2020-06-17Common Stock (50,000 underlying)
    50,000
  • Stock Options (to buy)

    Exercise: $20.45From: 2011-02-25Exp: 2020-02-25Common Stock (103,506 underlying)
    103,506
  • Stock Options (to buy)

    Exercise: $41.32From: 2008-05-21Exp: 2018-05-20Common Stock (6,485 underlying)
    6,485
Footnotes (5)
  • [F1]50,000 shares of restricted stock were granted upon the Reporting Person's acceptance of employment as Chief Executive Officer. These shares vest in four equal increments on 7/1/10, 7/1/11, 7/1/12 and 7/1/13.
  • [F2]The price shown is a weighted average; the shares were sold at prices ranging from $25.70 to $25.77. Upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
  • [F3]The options vest in three equal installments on 6/17/11, 6/17/12 and 6/17/13.
  • [F4]The options vest in three equal installments on 2/25/11, 2/25/12 and 2/25/13.
  • [F5]The options vest in four equal installments of 50,000 on 7/1/10, 7/1/11, 7/1/12 and 7/1/13.

Issuer

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

CIK 0001003124

Entity typeother

Related Parties

1
  • filerCIK 0001264908

Filing Metadata

Form type
4
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 4:15 PM ET
Size
18.6 KB